Does My Insurance Cover Off-Label Prescriptions - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Advertise
    • Contact
    • Editorial Staff
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
September 9, 2024 Newswires
Share
Share
Tweet
Email

Does My Insurance Cover Off-Label Prescriptions

U.S. Markets via PUBT

Key takeaways:

  • Off-label prescribing is when a medication is prescribed for a purpose not approved by the FDA.

  • Insurance might cover off-label prescriptions, but it depends on the specific plan and often requires a prior authorization.

  • Medicare and Medicaid may cover off-label prescriptions if recognized medical sources support them.

Access savings on related medications

info_outlinedPromotional disclosure
OzempicMounjaro

Table of contents

What is off-label?
Insurance coverage
Insurance evaluation
How to get coverage
Medicare
Medicaid
Off-label prescribing
Examples
Pros and cons
Bottom line
References
Vasil Dimitrov/E+ via Getty Images

Healthcare professionals work hard to find the best treatments for your health conditions. Sometimes, that means prescribing medications for uses they weren't approved for. This is referred to as "off-label" prescribing.

While taking medication for an off-label use might be the best option for treating your health condition, your insurance plan may not cover it since it's not an FDA-approved use. And if your plan does cover the medication, there are specific criteria that must be met.

What are off-label prescriptions?

An off-label prescription is when a medication is prescribed in a way that isn't FDA-approved. But why would a healthcare professional recommend a medication for off-label use?

EXPERT PICKS: WHAT TO READ NEXT
  • What can you do if your insurance plan doesn't cover your prescription costs? If your medication isn't covered, try taking these steps.

  • What's a prior authorization? This "approval of coverage" is required by insurance companies for some prescription medications. Here's what to know about the prior authorization process.

  • Did you know you can file an appeal if your off-label prescription is denied? Leahow to write an appeal letter to your insurance provider.

When a new medication is created, it's tested for specific uses. Then, it's FDA-approved for these specific uses if it's considered safe and effective. However, the medication may also be effective for other health conditions for which it's not FDA-approved. If it's prescribed for these uses, it's considered "off-label."

You might be wondering why medications with off-label uses don't just become FDA-approved for these uses. To get the FDA to approve these off-label uses, medication manufacturers need to do additional clinical trials. This takes time and money. As a result, some older medications that work well for unapproved uses remain off-label. This is often the case, for example, for many cancer medications. Insurance companies then have to decide how to handle coverage for these off-label uses.

Examples of off-label prescription use include:

  • Using a medication for a different health condition than the ones it's approved for: For example, a chemotherapy medication approved for one type of cancer might be used to treat a different type of cancer.

  • Giving a medication in a different form: For instance, a medication may come as a tablet and oral solution. They may be approved for different health conditions but used interchangeably.

  • Prescribing a different dosage than the approved amount: For example, if a medication dosage is approved as 1 tablet daily, a healthcare professional might tell you to take 2 tablets daily because they think a higher dose is best for you.

  • Using a medication approved for adults in children: For instance, a blood pressure medication approved for adults might be prescribed to treat the same condition in a child.

Popular stories this week

4 Tips for When Insurance Doesn't Cover Your Medication
Prescription Refill Rules and Emergency Refills
How Much Does an Ambulance Ride Cost?
Prior Authorizations: What You Need to Know
View more

Off-label prescribing is legal and more common than many people realize. Healthcare professionals may choose this option when they believe it's the best treatment. This is especially true if approved treatments haven't worked.

Does insurance cover off-label use?

It might. But some insurance plans have lists of specific off-label uses they won't cover. Whether insurance covers off-label medications depends on several factors, including:

  • Insurance provider

  • Policy exclusions

  • Intended use

For example, Ozempic (semaglutide) and Mounjaro (tirzepatide) are popular glucagon-like peptide-1 (GLP-1) medications used to treat Type 2 diabetes, but they're often prescribed off-label for weight loss. While your insurance may cover these medications for Type 2 diabetes, it's unlikely it will cover them for weight management, since they're not FDA-approved for that purpose. However, other GLP-1 medications - such as Wegovy (semaglutide) and Zepbound (tirzepatide) - are FDA-approved for chronic weight management,so there's a higher chance your insurance may cover them.

How do insurance plans evaluate off-label prescriptions?

A health plan might review off-label use requests by considering a few factors, such as:

  • If the medication is FDA-approved

  • Whether it's being used for a serious or rare condition

  • If standard treatments haven't worked

  • Whether the medication is listed in an approved compendium (a database compiled by experts who review and rate different medications and their uses, including some off-label uses)

How to get insurance to cover off-label prescriptions

Generally, to get insurance coverage for off-label prescriptions, you'll need a prior authorization. This means your prescriber will submit a request to your insurance company. The request explains why the off-label medication is medically necessary for you. Part of this review may include making sure you've tried FDA-approved options first.

It's a good idea to check with your health insurer about its policies on off-label coverage. Ask about any requirements or restrictions it may have. Also, find out if it has a list of approved off-label uses. This can help you understand your coverage options before starting an off-label medication.

Will Medicare cover off-label prescriptions?

Medicare may cover off-label prescriptions, but it depends on several factors. First, the medication must be FDA-approved for at least one use. Additionally, the medication must be "medically accepted." This means the use should be listed or supported in an approved compendium. It must also be backed by medical research or accepted as standard medical practice.

In some cases, healthcare professionals can ask for approval for off-label use by showing evidence from clinical trials. This evidence can come from at least two large studies (called Phase III trials) that show that the medication is safe and effective for the new use. If these aren't available, two smaller studies (Phase II trials) might be considered.

Medicare also considers whether respected medical groups recommend the off-label use.

For cancer treatments, Medicare has specific guidelines for covering off-label uses. These medications may be covered if they're listed in certain approved sources. Medicare also looks at evidence from peer-reviewed medical journals when deciding whether to cover an off-label cancer treatment. However, if a use is identified as unsafe or ineffective by Medicare, the FDA, or an approved database, the prescription won't be covered.

Will Medicaid cover off-label prescriptions?

Medicaid generally covers prescription medications that the FDA has approved. But for off-label uses, Medicaid has specific rules. Medicaid programs are only required to cover off-label prescriptions if there's strong support for that use in certain recognized sources.

However, Medicaid is a state-specific program. This means states have some flexibility in managing their Medicaid medication coverage. They can require prior authorization for any covered outpatient medication. States can also choose not to cover a medication for off-label use if it's not considered medically accepted or if the state has excluded it from its formulary (list of covered medications).

When can healthcare professionals prescribe medication for off-label use?

Healthcare professionals can prescribe medications for off-label use when they think it's the best treatment option. They use their medical judgment and scientific evidence to make this decision. Off-label prescriptions may also be prescribed when new research suggests a different use for an existing medication.

Here are some instances when off-label prescribing is used:

  • Children: Many medications aren't tested in children. Because of this, healthcare professionals may prescribe adult medications off-label for children.

  • Cancer treatment: Healthcare professionals might use a medication approved for one type of cancer to treat a different type.

  • Mental health conditions: Some medications originally approved for one mental health condition may be prescribed off-label for other conditions.

  • Rare health conditions: There may not be any FDA-approved treatments for some rare health conditions. These disorders aren't common but can be serious or life-threatening. In these cases, healthcare professionals might use medications off-label to help people with these conditions.

Examples of common medications that are prescribed off-label

Many medications approved for conditions such as pain, seizures, diabetes, or depression are often prescribed off-label to treat different health issues. Here are some common examples:

Medication

FDA-approved use

Off-label use

Trazodone

Depression in adults

Insomnia, fibromyalgia

Metformin (Glucophage)

Type 2 diabetes

Weight loss

Ozempic

Type 2 diabetes and to reduce the risk of heart problems in adults with Type 2 diabetes and heart disease

Weight loss (without a diabetes diagnosis)

Mounjaro

Type 2 diabetes

Weight loss (without a diabetes diagnosis)

Propranolol (Inderal)

High blood pressure, tremors, and migraine prevention

Performance anxiety

Gabapentin (Neurontin)

Seizures and nerve pain from shingles

Alcohol use disorder, anxiety

Escitalopram (Lexapro)

Depression and generalized anxiety disorder

Social anxiety disorder, obsessive-compulsive disorder (OCD), and premenstrual dysphoric disorder (PMDD)

Spironolactone (Aldactone)

Heart failure, high blood pressure, and swelling caused by kidney or liver issues in adults

Acne and hirsutism (excess hair growth in women)

What are the advantages and disadvantages of off-label use?

Off-label use can be helpful in many ways. It gives healthcare professionals more choices when approved treatments don't work. This is often useful for rare health conditions that don't have many approved treatments. Sometimes, using medications off-label can be more cost-effective, particularly when older, less costly medications work just as well as newer, pricier ones. It may also mean quicker access to effective treatments without waiting for the lengthy FDA approval processes.

But, off-label use also comes with risks. Medications used off-label haven't been fully tested for the new use, so we're less sure about their safety and effectiveness. Figuring out the right dosage of an off-label medication can also be tricky. Plus, there might be unexpected side effects.

As mentioned, insurance coverage can be an issue. Also, you might not always understand that a medication is being prescribed off-label and what that means. That's why it's important to have open discussions with your prescriber and ask questions such as:

  • Is this medication being prescribed for an FDA-approved use or off-label?

  • Why do you think this off-label use is the best option for my condition?

  • What are the potential benefits and risks of using this medication off-label?

  • Are there any FDA-approved alternatives we should consider first?

  • Will my insurance cover this off-label prescription, and if not, what are my options?

The answers to these questions can help you better understand your treatment and make an informed decision.

The bottom line

Insurance coverage for off-label prescriptions depends on your health plan, the medication, and how it's being used. Medicare and Medicaid have specific rules for covering off-label uses. Private insurance plans vary in their coverage. Often, you'll need a prior authorization for off-label prescriptions. Don't hesitate to ask your prescriber about coverage options and alternatives. Also, check with your insurance provider before starting an off-label medication.

Why trust our experts?

Written by:

Maggie Aime, MSN, RN

Maggie's writing brings health topics to life for readers at any stage of life. With over 25 years in healthcare and a passion for education, she creates content that informs, inspires, and empowers.
Edited by:

Charlene Rhinehart, CPA

Charlene Rhinehart, CPA, is a personal finance editor at GoodRx. She has been a certified public accountant for over a decade.
Reviewed by:

Amy B. Gragnolati, PharmD, BCPS

Amy Gragnolati, PharmD, BCPS, is a pharmacy editor for GoodRx. Amy currently holds her pharmacist license in Georgia and California.
Our editorial standards
Meet our experts

References

Agency for Healthcare Research and Quality. (2015). Off-label drugs: What you need to know.

American Cancer Society. (2015). Off-label drug use.

View All References (10)

expand_more

Centers for Medicare & Medicaid Services. (2024). Drugs and biologicals, coverage of, for label and off-label uses.

Centers for Medicare & Medicaid Services. (n.d.). Medicare benefit policy manual: Chapter 15 - Covered medical and other health services.

Hoon, D., et al. (2019). Trends in off-label drug use in ambulatory settings: 2006-2015. Pediatrics.

National Institute on Aging. (2023). What are clinical trials and studies? National Institutes of Health.

National Cancer Institute. (2022). Off-label drug use in cancer treatment. National Institutes of Health.

National Organization for Rare Disorders. (n.d.). Rare disease database.

Office of the Law Revision Counsel United States Code. (1995). 42 USC 1396r-8: Payment for covered outpatient drugs.

UnitedHealthcare. (2024). Off-label/unproven specialty drug treatment.

U.S. Food & Drug Administration. (2018). Understanding unapproved use of approved drugs "off label."

Van Norman, G. A. (2023). Off-label use vs off-label marketing of drugs. JACC: Basic to Translational Science.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Leamore about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

thumb_up_outlinedthumb_down_outlined
print_outlinedemail_outlined

Subscribe and save.

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up.

Email address

Subscribe

I would also like to sign up for a free GoodRx account

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

Attachments

  • Original Link
  • Permalink

Disclaimer

GoodRx Holdings Inc. published this content on 09 September 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on September 09, 2024 at 18:20:51 UTC.

Older

AM Best Affirms Performance Assessment of First Indemnity Insurance Agency, Inc.

Newer

Cost to rise for health plans sold on and off Connecticut’s Affordable Care Act Exchange

Advisor News

  • Take advantage of the exploding $800B IRA rollover market
  • Study finds more households move investable assets across firms
  • Could workplace benefits help solve America’s long-term care gap?
  • The best way to use a tax refund? Create a holistic plan
  • CFP Board appoints K. Dane Snowden as CEO
More Advisor News

Annuity News

  • Court fines Cutter Financial $100,000, requires client notice of guilty verdict
  • KBRA Releases Research – Private Credit: From Acquisitions to Partnerships—Asset Managers’ Growing Role With Life/Annuity Insurers
  • $80k surrender charge at stake as Navy vet, Ameritas do battle in court
  • Sammons Institutional Group® Launches Summit LadderedSM
  • Protective Expands Life & Annuity Distribution with Alfa Insurance
More Annuity News

Health/Employee Benefits News

  • Data from Stanford University Provide New Insights into Managed Care (The environmental chemical exposome and health insurance: Examining associations and effect modification of epigenetic aging in a representative sample of United States adults): Managed Care
  • National Center for HIV Researcher Details Research in Health Insurance (Behavioral Readiness for Daily Oral PrEP in a Diverse Sample of Gay, Bisexual, and Other Men who have Sex with Men Who Have Not Been Offered PrEP by a Provider): Health Insurance
  • When health insurance costs more than the mortgage
  • Farmers Now Owe a Lot More for Health Insurance
  • Health care outlook: Volatility and potential coverage gaps
More Health/Employee Benefits News

Life Insurance News

  • John Hancock looks to new AI underwriting tool to slash processing time
  • AllianzIM Buffered ETF Suite Expands with Launch of International Fund
  • Author Sherida Stevens's New Audiobook, “INDEXED UNIVERSAL LIFE INSURANCE IN ACTION: FROM PROTECTION TO PROSPERITY – YOUR PATH TO FINANCIAL SECURITY,” is Released
  • AM Best Affirms Credit Ratings of Etiqa General Insurance Berhad
  • Life insurance application activity hits record growth in 2025, MIB reports
Sponsor
More Life Insurance News

- Presented By -

Top Read Stories

More Top Read Stories >

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Elevate Your Practice with Pacific Life
Taking your business to the next level is easier when you have experienced support.

LIMRA’s Distribution and Marketing Conference
Attend the premier event for industry sales and marketing professionals

Get up to 1,000 turning 65 leads
Access your leads, plus engagement results most agents don’t see.

What if Your FIA Cap Didn’t Reset?
CapLock™ removes annual cap resets for clearer planning and fewer surprises.

Press Releases

  • Prosperity Life Group appoints industry veteran Rona Guymon as President, Retail Life and Annuity
  • Financial Independence Group Marks 50 Years of Growth, Innovation, and Advisor Support
  • Buckner Insurance Names Greg Taylor President of Idaho
  • ePIC Services Company and WebPrez Announce Exclusive Strategic Relationship; Carter Wilcoxson Appointed President of WebPrez
  • Agent Review Announces Major AI & AIO Platform Enhancements for Consumer Trust and Agent Discovery
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Advertise
  • Contact
  • Editorial Staff
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.
Insurance News | InsuranceNewsNet